Controlled Decompression Alleviates Motor Dysfunction by Regulating Microglial Polarization via the HIF-1α Signaling

Jie Zheng1, Chenxu Zhang1, Yonghui Wu1

  • 1Department of Neurosurgery, The 904th Hospital of PLA, Wuxi Clinical College of Anhui Medical University, Wuxi, 214044, Jiangsu, China.

PubMed

Insights

Controlled decompression (CDC) reduces inflammation and neuronal death after traumatic intracranial hypertension (TIH) by shifting microglia to an anti-inflammatory M2 state, unlike rapid decompression (RDC). This mechanism involves regulating hypoxia-inducible factor-1α (HIF-1α).

Area of Science:

  • Neuroscience
  • Surgical Research
  • Inflammation Biology

Background:

  • Decompressive craniectomy (DC) is crucial for managing intracranial hypertension (IH) after severe traumatic brain injury (sTBI) and stroke.
  • Controlled decompression (CDC) shows promise over rapid decompression (RDC) in improving outcomes, but underlying mechanisms require elucidation.
  • Inflammation and microglial polarization are key factors in brain injury progression following IH.

Purpose of the Study:

  • To investigate the effects of CDC on regulating inflammation in a rat model of traumatic intracranial hypertension (TIH).
  • To identify the specific molecular mechanisms, particularly involving hypoxia-inducible factor-1α (HIF-1α), by which CDC exerts its protective effects.
  • To compare the impact of CDC versus RDC on microglial polarization and cytokine release.

Main Methods:

  • Established a rat model of TIH using epidural balloon pressurization.
  • Administered CDC and RDC, assessing motor function, neuronal death, and inflammatory markers.
  • Analyzed microglial polarization (M1 vs. M2 phenotypes) and cytokine profiles.
  • Investigated the role of HIF-1α using specific inhibitors (2-methoxyestradiol, 2-ME2) and agonists (dimethyloxaloylglycine, DMOG).

Main Results:

  • CDC significantly alleviated motor dysfunction and neuronal death compared to RDC.
  • RDC promoted pro-inflammatory M1 microglia polarization and cytokine release, while CDC induced anti-inflammatory M2 polarization and cytokine release.
  • CDC reduced HIF-1α expression, and manipulating HIF-1α levels (via 2-ME2 or DMOG) confirmed its role in mediating CDC's anti-inflammatory and neuroprotective effects.
  • CDC ameliorated cerebral hypoxia and reduced HIF-1α expression.

Conclusions:

  • Controlled decompression (CDC) effectively mitigates inflammation, neuronal death, and motor deficits in a rat model of traumatic intracranial hypertension (TIH).
  • The protective mechanisms of CDC involve the regulation of HIF-1α-mediated microglial phenotype polarization towards an anti-inflammatory M2 state.
  • These findings enhance understanding of CDC's benefits and support further clinical research into HIF-1α targeted therapies for IH.